Table 2.
Response of RR-AML patients with FLAG and DAC treatment
| Response | FLAG group (n=18) |
DAC group (n=17) |
Total (n=35) |
P-value |
|---|---|---|---|---|
| NR (%) | 8 (44.4) | 0 (0) | 8 (22.8) | – |
| OR (%) | 10 (55.6) | 17 (100) | 27 (77.1) | 0.002 |
| CR (%) | 6 (33.3) | 11 (64.7) | 17 (48.6) | 0.002 |
Abbreviations: CR, complete response; DAC, low-dose decitabine with aclacinomycin and cytarabine; FLAG, fludarabine in combination with cytarabine and G-CSF; NR, no response; OR, overall response; RR-AML, relapsed/refractory acute myeloid leukemia.